Adjuvant therapy of breast cancer patients
Semiglazov, V.F.; Bavli, I.L.; Moiseenko, V.M.
Voprosy Onkologii 32(11): 59-63
1986
ISSN/ISBN: 0507-3758 PMID: 3097961 Document Number: 277697
The paper discusses the state of the art in adjuvant treatment of breast cancer patients. The protocol of the randomized controlled study of the effectiveness of adjuvant chemohormonotherapy conducted at the Petrov Institute since January, 1985 is presented. It is suggested that all oncological institutions concerned should take part in a cooperative investigation to be carried out along the guidelines outlined in the protocol.
Document emailed within 1 workday
Related Documents
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Yoshida, M.; Saji, S.; Takagi, H.; Takeuchi, S.; Tsuda, H.; Nimura, Y.; Mizumoto, R.; Miyazaki, I.; Kobayashi, S.; Noguchi, M. 1993: A comparative study among ftorafur, ftorafur plus tamoxifen, and tamoxifen in adjuvant therapy for breast cancer. the Chubu Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2325-2333
Kurebayashi, J. 2006: Postoperative adjuvant therapy for premenopausal patients with breast cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 64(10): 1963-1969
Semiglazov, V.F.; Moiseenko, V.M.; Ivanova, O.A. 1986: Prospective randomized study of the efficacy of adjuvant hormone therapy in patients with breast cancer Voprosy Onkologii 32(8): 31-34
Rose, D.P.; Davis, T.E. 1980: Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients Cancer Research 40(11): 4043-4047
Overgaard, M. 2000: Evaluation of radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy Rays 25(3): 325-330
Castiglione-Gertsch, M.; Tattersall, M.; Hacking, A.; Goldhirsch, A.; Gudgeon, A.; Gelber, R.D.; Lindtner, J.; Coates, A.; Collins, J.; Isley, M.; Senn, H.J.; Rudenstam, C.M. 1997: Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group European Journal of Cancer 33(14): 2321-2325
Nesković-Konstantinović, Z.; Filipović, S. 2003: The role of endocrine therapy in early breast cancer: adjuvant treatment of preand postmenopausal patients Journal of Buon: Official Journal of the Balkan Union of Oncology 8(1): 11-17
Uhlenbruck, G.; VAN Leendert, R.; Schneider, B.; Beuth, J. 2010: Reduced side-effects of adjuvant hormone therapy in breast cancer patients by complementary medicine In Vivo 24(5): 799-802
Ogawa, Y.; Aono, T.; Yamada, T.; Nishikawa, K.; Ikeda, K.; Tokunaga, S.; Okawa, K.; Ikehara, T. 2010: Evaluation of liaison-clinical pathway for patients with breast cancer undergoing adjuvant therapy after curative operation--data from questionnaire survey of 56 clinics and 105 patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(8): 1477-1481
Mitsuyama, S.; Kuroda, Y.; Ohsato, K.; Nakamura, Y.; Murakami, F.; Nishikata, F.; Ikeda, S.; Egami, T.; Mori, A.; Ohe, H. 1996: Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1153-1160
Bahena, J.; Labastida Almendaro, S.; Ayala Hernández, J.R.; Fernández Orozco, A. 1998: Impact of the interval between surgery and radiotherapy in the initial phases of breast cancer in patients who did not receive systemic adjuvant therapy Ginecologia y Obstetricia de Mexico 66: 87-91
Nomura, Y.; Yamagata, J.; Kondo, H.; Takenaka, K. 1978: Endocrine adjuvant therapy with the antiestrogen, mepitiostane, inoperable breast cancer patients on the basis of estrogen receptor assay Gan 69(2): 281-282
Crivellari, D. 2002: Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group Tumori 88(1 Suppl. 1): S81-S82
Liang, X.-f.; Ma, D.-c.; Ding, Z.-y.; Liu, Z.-z.; Guo, F.; Liu, L.; Yu, H.-y.; Han, Y.-l.; Xie, X.-d. 2013: Autologous cytokine-induced killer cells therapy on the quality of life of patients with breast cancer after adjuvant chemotherapy: a prospective study Zhonghua Zhong Liu Za Zhi 35(10): 764-768
Melnychuk, D.; Panasci, L.C. 1994: Adjuvant therapy for breast cancer New England Journal of Medicine 331(11): 741
Semiglazov, V.F. 2000: Adjuvant therapy in breast cancer Voprosy Onkologii 46(1): 18-27
Yoshida, M. 1986: Adjuvant therapy of breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(4 Part 2): 1547-1554
Garey, J.; Lehrer, S. 1994: Adjuvant therapy for breast cancer New England Journal of Medicine 331(11): 742